Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
8 hedge funds and large institutions have $2.95M invested in Yield10 Bioscience, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less funds holding
Funds holding: 10 → 8 (-2)
61% less capital invested
Capital invested by funds: $7.62M → $2.95M (-$4.67M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$395K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.38M |
| 2 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$45.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$22.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$4K |
YTEN Hedge Fund Activity: Q2 2016 in Review
8 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2016, worth a combined $2.95M — down 61% from $7.62M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of YTEN and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was GMT Capital, opening a new position worth an estimated $395K. The largest seller was Oracle Investment Management, exiting entirely with an estimated $1.38M sold.
- 8 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2016, down from 10 in Q1 2016.
- Funds reported $2.95M of Yield10 Bioscience, Inc. Common Stock stock for Q2 2016, down 61% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2016 and 3 closed out, a net change of -2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q2 2016 was GMT Capital, an estimated $395K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2016 was Oracle Investment Management, an estimated $1.38M sold.
Based on aggregated 13F filings for Q2 2016.